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Cole Disease Results from Mutations in ENPP1
Ori Eytan,1,2,11 Fanny Morice-Picard,3,4,11 Ofer Sarig,1 Khaled Ezzedine,3,4 Ofer Isakov,5 Qiaoli Li,6,7
Akemi Ishida-Yamamoto,8 Noam Shomron,5 Tomer Goldsmith,1 Dana Fuchs-Telem,1,2 Noam Adir,9
Jouni Uitto,6,7 Seth J. Orlow,10 Alain Taieb,3,4,* and Eli Sprecher1,2,*
The coexistence of abnormal keratinization and aberrant pigmentation in a number of cornification disorders has long suggested a
mechanistic link between these two processes. Here, we deciphered the genetic basis of Cole disease, a rare autosomal-dominant geno-
dermatosis featuring punctate keratoderma, patchy hypopigmentation, and uncommonly, cutaneous calcifications. Using a combina-
tion of exome and direct sequencing, we showed complete cosegregation of the disease phenotype with three heterozygous ENPP1
mutations in three unrelated families. All mutations were found to affect cysteine residues in the somatomedin-B-like 2 (SMB2) domain
in the encoded protein, which has been implicated in insulin signaling. ENPP1 encodes ectonucleotide pyrophosphatase/phosphodies-
terase 1 (ENPP1), which is responsible for the generation of inorganic pyrophosphate, a natural inhibitor of mineralization. Previously,
biallelic mutations in ENPP1 were shown to underlie a number of recessive conditions characterized by ectopic calcification, thus
providing evidence of profound phenotypic heterogeneity in ENPP1-associated genetic diseases.Cole disease is a rare autosomal-dominant disorder that
has been reported in four families since its original descrip-
tion in 1976.1 The disorder is characterized by congenital
or early-onset punctate keratoderma associated with irreg-
ularly shaped hypopigmentedmacules, which are typically
found over the arms and legs, but not the trunk or acral
regions.1–4 Extracutaneous involvement has not been
reported. The pathogenesis of the disorder has remained
elusive. Skin biopsies obtained from palmoplantar lesions
show hyperorthokeratosis, hypergranulosis, and acantho-
sis and are therefore not indicative of any specific
pathomechanism.2,3 In contrast, upon histopathological
examination, hypopigmented areas of the skin demon-
strate a reduction in melanin content in keratinocytes,
but not in melanocytes, as well as hyperkeratosis and a
normal number of melanocytes.4 Accordingly, ultrastruc-
tural studies have revealed that melanocytes show a
disproportionately large number of melanosomes in the
cytoplasm and dendrites but that keratinocytes show a
paucity of these organelles, suggestive of impairedmelano-
some transfer.4
Attempts at identifying the molecular basis of Cole dis-
ease through sequencing of candidate genes associated
with overlapping phenotypes, such as epidermolysis bul-
losa simplex with mottled pigmentation (MIM 131960)
and Naegeli syndrome (MIM 161000), have failed to reveal
causative mutations.2 In the present report, using a
genome-wide approach, we demonstrate that mutations
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Cole disease.
We studied three families affected by the disorder
(Figure 1A). Families A and C are of French origin and
have not been reported previously. Family B has been pre-
viously described2 and originates from the United States.
All affected individuals displayed similar clinical and histo-
pathological features, as detailed in Table 1. In brief,
affected individuals developed hypopigmented macules
mainly located over the extremities and hyperkeratotic
papules over the palms and soles (Figures 1B–1C). Age of
onset varied between 3 months and 1 year.
All participants provided written informed consent to
participate in this study according to a protocol reviewed
and approved by our institutional review boards. Genomic
DNA was extracted either from whole-blood samples with
the 5 Prime ArchivePure DNA Blood Kit (5 PRIME) or from
saliva collection kits (DNA Genotek). To identify the caus-
ative mutations underlying Cole syndrome in our families,
we used DNA samples from individuals II-1, II-3, III-2, and
III-4 from family A and from individual II-1 from family B
for whole-exome capture and next-generation sequencing.
Exome sequencing was performed by Macrogen (family A)
or by Galil Genetic Analysis (family B) with the samemeth-
odology. Whole-exome capture was done by in-solution
hybridization with TruSeq (Illumina) and subsequent
massive parallel sequencing (Illumina HiSeq2000) with
100 bp paired-end reads. Reads were aligned to GRCh37
(UCSC Genome Browser hg19) with the Burrows-Wheeler5, Israel; 2Department of Human Molecular Genetics & Biochemistry, Sack-
ment of Dermatology and Pediatric Dermatology, National Center for Rare
nal de la Sante´ et de la Recherche Me´dicale 1035, University of Bordeaux
Medicine, Tel-Aviv University, Ramat-Aviv 69978, Israel; 6Departments of
y, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA
iversity, Philadelphia, PA 19107, USA; 8Department of Dermatology, Asahi-
mistry, Technion-Israel Institute of Technology, Technion City, Haifa 32000,
ersity School of Medicine, New York, NY 10016, USA
il (E.S.)
y of Human Genetics. All rights reserved.
3, 2013
Figure 1. Clinical Features
(A) Pedigrees of the three families affected
by Cole disease. Black symbols denote
affected individuals. Individuals who
were genotyped for mutations in ENPP1
are marked with an asterisk.
(B) Hypopigmented macules over the left
forearm of individual III-4.
(C) Hyperkeratotic papules over the left
foot of individual III-4.Aligner.6 Duplicate reads, resulting from PCR clonality or
optical duplicates, and reads mapping to multiple loca-
tions were excluded from downstream analysis. Reads
mapping to a region of known or detected indels were real-
igned for minimizing alignment errors. Single-nucleotide
substitutions and small indels were identified and quality
filtered with the Genome Analysis Toolkit.7 Rare variants
were identified by filtering using the data from dbSNP135,
the 1000 Genomes Project, the National Heart, Lung, and
Blood Institute (NHLBI) Exome Sequencing Project Exome
Variant Server, and an in-house database of 110 sequenced
individuals. Variants were classified by predicted protein
effects with PolyPhen-28 and SIFT.9 Exome sequencing de-
tails are summarized in Table S1, available online.
After filtering out variants with a minor allele frequency
greater than 0.01 or variants covered less than 103, we
identified a total of 275 variations present in affected indi-
viduals of both families. We then assumed that given the
separate origins of families A and B, causative mutations
should be different in each of them. This approach nar-
rowed our list of variations to nine nucleotide substitu-
tions, which we confirmed by direct sequencing. We
then proceeded by establishing the coding sequence of
each gene containing one of these nine variations in fam-The American Journal of Human Geily C. Among these genes,
ENPP1 (RefSeq accession number
NM_006208.2) was the only one
found to harbor three distinct muta-
tions: c.530G>A (p.Cys177Tyr) was
identified in family A, c.491G>C
(p.Cys164Ser) was discovered in fam-
ily B, and c.446G>C (p.Cys149Ser)
was detected in family C (Figure 2A).
ENPP1 encodes ENPP1, a cell-
surface protein that catalyzes the
hydrolysis of ATP to AMP and gener-
ates extracellular inorganic pyrophos-
phate (PPi).
10 Biallelic mutations in
ENPP1 have been shown to be associ-
ated with several inherited disorders
featuring either ectopic calcifications
or abnormal calcium handling,
including generalized arterial calcifi-
cation of infancy (MIM 208000),11
pseudoxanthoma elasticum (MIM
264800),12 and autosomal-recessivehypophosphatemic rickets type 2 (MIM 613312)13.
Despite the fact that ENPP1 has not been shown to date
to have any role in epidermal differentiation or skin
pigmentation, four findings support the notion that the
mutations we identified in this gene underlie Cole disease
in the three families we studied: (1) none of the three
mutations was found in dbSNP, the Human Gene
Mutation Database, the UCSC Genome Browser, 1000
Genomes, Ensembl, or the NHLBI Exome Variant Server,
including exome sequencing data for a total of 6,503 indi-
viduals; (2) using direct sequencing of ENPP1 in all
(healthy and affected) participants (Figure 1A), we
confirmed cosegregation of the mutations with the disease
phenotype in each of the three families (not shown); (3)
both the SIFT and the PolyPhen-2 protein-structure pre-
diction programs were found to attribute a maximal
damaging score to all three mutations (Table S2); and (4)
the three mutations identified affect highly conserved
cysteine residues (Table S2).
The fact that all three mutations affected residues
located within a small region of ENPP1 (Figure 2B) sup-
ports a role for this domain in the pathogenesis of the
disease. ENPP1 structure has been determined for
M. musculus14 (Protein Data Bank [PDB] ID 4B56), whichnetics 93, 752–757, October 3, 2013 753
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754 The American Journal of Human Genetics 93, 752–757, Octoberis 79% homologous to the human protein. Using the
SWISS-MODEL folding engine,15 we built a homology
model with subunit A of the 4B56 structure. The resulting
model included residues Lys106 to Ser922. Cys149,
Cys164, and Cys177, the three cysteines affected by the
mutations we identified in our families, are located on a
protracted substructure that extends out from the main
protein body (Figure 3A) and are involved in intramolecu-
lar disulphide bonds: Cys149-Cys166 and Cys164-Cys177
(Figure 3B). Six additional disulphide bonds present in the
M. musculus structure are also seen in the model of the
human protein (Figure 3B). The conservation of eight
disulphide bonds in a small region of the protein indicates
the need for precise positioning of the N terminus and also
indicates potential redox-regulated control mechanisms.
Disruption of these disulphide bonds is expected to impart
a large change on the local structure of this portion of the
protein and is therefore likely to exert a dominant-negative
effect. This contrasts with the mechanisms of action of
recessive ENPP1 mutations, which result in loss of ENPP1
expression and/or activity.16
The facts that ENPP1 has so far been implicated in the
prevention of ectopic calcification16 but that the Cole
disease phenotype mainly includes keratoderma and
hypopigmentation prompted us to review all clinical
data available for affected individuals. Interestingly, indi-
vidual III-4 of family A had been diagnosed with an
early-onset calcific tendinopathy of the shoulders and
Achilles tendon with chronic activity-related pain, and
individual II-3 of family A also presented with wrist cal-
cification suggestive of chondrocalcinosis and unusual
numerous breast microcalcifications detected on a ma-
mmography performed at 53 years of age (Table 1). In addi-
tion, calcified deposits in the dermis of the plantar surface
were present in individual II-1 of Family B, as previously re-
ported.2 Although these data lend further support to the
pathogenic role of ENPP1 mutations in Cole disease, they
do not explain their unique clinical manifestations.
ENPP1 consists of eight domains (Figure 2B).14 Most
mutations associated with ectopic calcification affect the
phosphodiesterase domain, which is thought to mediate
ENPP1 catalytic activity, or the nuclease domain.13 In
contrast, all three mutations identified as causing Cole
disease in this study affect residues clustered within the
somatomedin-B-like 2 (SMB2) domain of ENPP1
(Figure 2B), suggesting that this domain plays a role in
the regulation of epidermal pigmentation and differ-
entiation. ENPP1 belongs to a family of seven ectonucleo-
tide pyrophosphatases/phosphodiesterases, only three of
which possess the SMB2 domain.17
Not only does ENPP1 negatively regulate mineralization
by hydrolyzing extracellular nucleoside triphosphates to
produce PPi, but it has also been shown to inhibit insulin
signaling18 through the interaction between its SMB2
domain and insulin receptor.19 These observations might
be of direct relevance to the pathogenesis of Cole disease.
Indeed, insulin signaling plays a critical role in epidermal3, 2013
Figure 2. Mutation Analysis
(A) Direct sequencing of ENPP1 revealed three heterozygousmutations in exon 4 of the gene: c.530G>A in family A, c.491G>C in family
B, and c.446G>C in family C.
(B) ENPP1 mutations cataloged in the Human Gene Mutation Database and mutations causing Cole disease are marked along a sche-
matic representation of ENPP1. All three mutations causing Cole disease uniquely affect cysteine residues located within the SMB2
domain of ENPP1.homeostasis20 and interacts with other systems important
for keratinocyte differentiation, including epidermal-
growth-factor-dependent signaling21 which has been
implicated in the pathogenesis of punctate palmoplantar
keratoderma (MIM 148600).22,23 Moreover, as mentioned
above, previous histopathological and ultrastructural
studies have suggested a block in melanin transfer from
melanocytes to keratinocytes as the basis for the develop-
ment of hypopigmented patches in Cole disease.4 As mela-
nosome uptake by keratinocytes is largely mediated by
proteinase-activated receptor 2 (PAR-2),24 and because
PAR-2 activity is under the negative regulation of the insu-
lin signaling pathway,25 impaired inhibition of this
pathway by ENPP1 is expected to lead to decreased transferThe Americof melanosomes to keratinocytes. Impaired ENPP1 regula-
tion of insulin signaling is expected to be of physiological
consequence in the context of specific tissues only as at-
tested by the fact that we could not find any evidence of
systemic impaired glucose handling in affected individuals
(Table 1).
In summary, our data provide genetic evidence of an
unexpected role for ENPP1 in the regulation of epidermal
differentiation and pigmentation.Supplemental Data
Supplemental Data include two tables and can be found with this
article online at http://www.cell.com/AJHG.an Journal of Human Genetics 93, 752–757, October 3, 2013 755
Figure 3. Protein Modeling
(A) We modeled human ENPP1 (residues
Lys106 to Ser922) on the basis of the crys-
tal structure previously determined for the
mouse homolog (PDB ID 4B56). Using
SWISS-MODEL folding engine 15, we built
a homology model with subunit A of the
4B56 structure. The model is spectrally
colored from the N terminus (blue) to the
C terminus (red). Residues Cys149,
Cys164, and Cys177 are located on a pro-
tracted substructure that extends out
from the main protein body (black oval).
(B) Enlarged view of the encircled region of
(A). The protein backbone is in cyan. The
intramolecular disulphide bonds involving
the altered residues (Cys149-Cys166 and Cys164-Cys177) in Cole disease are depicted as sticks, and C, N, O, and S atoms are colored in
cyan, blue, red, and yellow, respectively. Six additional disulphide bonds are represented as thin lines with the same color coding.Acknowledgments
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